Reaction
Nasal Polypectomy reporting signals
As of the last recalculation, Nasal Polypectomy appears in 151 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is MEPOLIZUMAB (PRR 108.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mepolizumab | 31 | 108.0 | 108.0 |
| Dupilumab | 75 | 41.6 | 41.7 |